Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer.
Kataoka K, Suzuki R, Taniguchi H, Noda Y, Shindoh J, Matsumoto S, Watanabe Y, Honda K, Suzuki K, Baba K, Imaizumi K, Kume H, Hasegawa Y, Takagi K.
Kataoka K, et al. Among authors: honda k.
Lung. 2006 May-Jun;184(3):133-9. doi: 10.1007/s00408-005-2572-1.
Lung. 2006.
PMID: 16902837
Clinical Trial.